摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,4aS,6R,10S,12S,12aR)-4-(tert-Butyldimethylsiloxy)-1,2,4,4a,5,6,10,11,12,12a-decahydro-6,8-dihydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one | 150931-03-6

中文名称
——
中文别名
——
英文名称
(4R,4aS,6R,10S,12S,12aR)-4-(tert-Butyldimethylsiloxy)-1,2,4,4a,5,6,10,11,12,12a-decahydro-6,8-dihydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one
英文别名
——
(4R,4aS,6R,10S,12S,12aR)-4-(tert-Butyldimethylsiloxy)-1,2,4,4a,5,6,10,11,12,12a-decahydro-6,8-dihydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one化学式
CAS
150931-03-6
化学式
C26H46O6Si
mdl
——
分子量
482.733
InChiKey
MLADZCVSXWCRIU-MLJUQEBCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为反应物:
    描述:
    (4R,4aS,6R,10S,12S,12aR)-4-(tert-Butyldimethylsiloxy)-1,2,4,4a,5,6,10,11,12,12a-decahydro-6,8-dihydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one 在 lithium aluminium tetrahydride 作用下, 以 乙醚 为溶剂, 反应 1.0h, 以97%的产率得到(4R,4aS,6R,7S,12S,12aR)-4-(tert-Butyldimethylsiloxy)dodecahydro-6,7-dihydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-8(2H)-one
    参考文献:
    名称:
    A-Ring oxygenation studies in bridgehead hydroxyl-substituted trans-tricyclo[9.3.1.03,8]pentadecan-14-one congeners of taxol
    摘要:
    The ready availability of 5 has prompted examination of a convenient means for carbonyl transposition in its A-ring. Attempts to implement such chemistry directly on 5 and its silyl-protected derivative suffer from a kinetic proclivity for transannular capture of the enolate anion. This undesirable process was circumvented by reduction of the C9 carbonyl following conversion to silyl enol ether 8. Once the resulting 9alpha-alcohol was protected as its MOM ether, the enolates of 10a and 10b could be efficiently oxygenated at C13 by treatment with the Davis sulfonyl oxaziridine despite severe steric congestion in that locale. The resultant alpha-alcohol 11a could be epimerized to the 13beta-isomer by exposure to potassium hexamethyldisilazide. Remarkably, 11a is prone to autoxidation, although the yield of diketone 12 is capricious. A preferred route to this key intermediate involves periodinane oxidation of 11a. Reduction of 12 and its O-silylated derivative has provided the targeted compounds 15 and 16, respectively. The conformational features of various intermediates are discussed in the light of NMR studies and MM2 calculations.
    DOI:
    10.1021/jo00070a037
  • 作为产物:
    描述:
    (4R,4aS,6R,8R,10R,12S,12aR)-4-(tert-Butyldimethylsiloxy)dodecahydro-6,8-dihydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one 在 戴斯-马丁氧化剂 作用下, 以 二氯甲烷 为溶剂, 反应 0.17h, 以85%的产率得到(4R,4aS,6R,10S,12S,12aR)-4-(tert-Butyldimethylsiloxy)-1,2,4,4a,5,6,10,11,12,12a-decahydro-6,8-dihydroxy-12-(methoxymethoxy)-12a,13,13-trimethyl-6,10-methanobenzocyclodecen-7(1H)-one
    参考文献:
    名称:
    A-Ring oxygenation studies in bridgehead hydroxyl-substituted trans-tricyclo[9.3.1.03,8]pentadecan-14-one congeners of taxol
    摘要:
    The ready availability of 5 has prompted examination of a convenient means for carbonyl transposition in its A-ring. Attempts to implement such chemistry directly on 5 and its silyl-protected derivative suffer from a kinetic proclivity for transannular capture of the enolate anion. This undesirable process was circumvented by reduction of the C9 carbonyl following conversion to silyl enol ether 8. Once the resulting 9alpha-alcohol was protected as its MOM ether, the enolates of 10a and 10b could be efficiently oxygenated at C13 by treatment with the Davis sulfonyl oxaziridine despite severe steric congestion in that locale. The resultant alpha-alcohol 11a could be epimerized to the 13beta-isomer by exposure to potassium hexamethyldisilazide. Remarkably, 11a is prone to autoxidation, although the yield of diketone 12 is capricious. A preferred route to this key intermediate involves periodinane oxidation of 11a. Reduction of 12 and its O-silylated derivative has provided the targeted compounds 15 and 16, respectively. The conformational features of various intermediates are discussed in the light of NMR studies and MM2 calculations.
    DOI:
    10.1021/jo00070a037
点击查看最新优质反应信息

同类化合物

黄药子素C 黄独素A 香紫苏内酯 降龙涎香醚 阿霉素(α-β混合物) 银线草内酯醇 辛辣木素 载脂蛋白-土霉素 萘并[2,3-c]呋喃-3(1H)-酮 萘并[2,3-c]呋喃-1,3-二酮,5,8-二甲基-(9CI) 萘并[2,3-c]呋喃-1(3H)-酮,4-(3-呋喃基)-7-羟基- 萘并[2,3-b]呋喃-4,9-二酮,2,3-二氢-2-甲基-2-苯基- 萘并[2,1-b]呋喃-2-甲酰肼 萘并[2,1-b]呋喃-2(1H)-酮 萘并[2,1-b]呋喃-1-乙酸 萘并[1,2-b]呋喃-2-醇,2,3,3a,4,5,5a,6,7,9a,9b-十氢-3,5a,9-三甲基- 萘并[1,2-b]呋喃-2(3H)-酮,3a,4,5,9b-四氢-8-羟基-3,9-二甲基-,(3R,3aR,9bS)-rel- 萘并(2,3-b)呋喃-4,9-二酮 萘[2,1-b]呋喃-2-羧酸乙酯 萘[2,1-B]苯并呋喃-10-基硼酸 荧蒽-2,3-二甲酸酐 苯并[g][1]苯并呋喃-8,9-二酮 苯并[g][1]苯并呋喃-3-酮 苯并[g][1]苯并呋喃-2-甲醛 苯并[g][1]苯并呋喃 苯并[f][1]苯并呋喃-3-酮 苯并[e][1]苯并呋喃-8-醇 苯并[e][1]苯并呋喃-1-酮 苯并[e][1]苯并呋喃 苯并[b]萘并[2,3-d]呋喃 苯并[b]萘并[2,1-d]呋喃 苯并[b]萘并[1,2-d]呋喃 苯并[B]萘并[2,3-D]呋喃-2-羟基硼酸 苯基利福平 苯基(6,7,8,9-四氢萘并[2,1-b]呋喃-2-基)甲醇 苊并[5,4-b]呋喃-4,5-二酮,7,8-二氢-3,6-二羟基-1,7,7,8-四甲基-,(8S)- 维生素K1相关化合物 红葱酚 盐(1:2)苯磺酸,2,2'-(1,2-乙烯二基)二[5-[[4,6-二(2-萘氧基)-2-嘧啶基]氨基]-,钠 白术内酯 I 珀勒内B 珀勒内A 沃拉帕沙杂质 沃拉帕沙 沃拉帕沙 沃拉帕沙 己二酸,聚合2,2-二(羟甲基)-1,3-丙二醇,1,3-异苯并呋喃二酮和2,2-氧代二乙醇,2-丙烯酸酯 岩大戟内酯B 岩大戟内酯A 密叶辛木素